Management of anterior ST-elevation myocardial infarction presenting more than 48 hours from symptom onset without reperfusion therapy in the cardiac care unit
Abstract
ST-elevation myocardial infarction is a form of acute coronary syndrome that is the leading cause of death worldwide. Treatment with reperfusion therapy in the form of primary percutaneous intervention is the main treatment to reduce morbidity and mortality. However, reperfusion therapy is not recommended for patients presenting with symptoms onset of more than 48 hours. A 62-year-old male patient was diagnosed with anterior STEMI with symptoms onset of more than 48 hours based on complaints of anginal chest pain and shortness of breath. ST-segment elevation in V1-V4 and pathological Q in V1-V3 on ECG and increased hs-Troponin I was reported. The patient was not treated with reperfusion therapy based on treatment recommendations. The patient was given vasodilators, beta-blockers, statins, heparinization, and comorbid infection control in the cardiac care ward. Clinical improvement was obtained, and the patient was discharged after seven days of hospitalization and then was planned for Dobutamine Stress Echo during the follow-up visit. Conservative management and viability testing are the main options for patient management in STEMI with symptom onset of more than 48 hours without any complaints of chest pain, stable hemodynamics, and no life-threatening arrhythmia.
References
Bello, D., Fieno, D. S., Kim, R. J., Pereles, F. S., Passman, R., Song, G., … Goldberger, J. J. (2005). Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. Journal of the American College of Cardiology, 45(7), 1104–1108. https://doi.org/10.1016/j.jacc.2004.12.057
Bhat, A., Gan, G. C. H., Tan, T. C., Hsu, C., & Denniss, A. R. (2016). Myocardial Viability: From Proof of Concept to Clinical Practice. Cardiology Research and Practice, 2016. https://doi.org/10.1155/2016/1020818
Boekholdt, S. M., Hovingh, G. K., Mora, S., Arsenault, B. J., Amarenco, P., Pedersen, T. R., … Kastelein, J. J. P. (2014). Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials. Journal of the American College of Cardiology, 64(5), 485–494. https://doi.org/10.1016/j.jacc.2014.02.615
Canty Jr., J. M., Suzuki, G., Banas, M. D., Verheyen, F., Borgers, M., & Fallavollita, J. A. (2005). Hibernating Myocardium: Chronically Adapted to Ischemia but Vulnerable to Sudden Death. Circulation Research, 94, 1142–1149. https://doi.org/10.1161/01.res.0000125628.57672.cf
Clifford, C. R., Le May, M., Chow, A., Boudreau, R., Fu, A. Y. N., Barry, Q., … So, D. Y. F. (2021). Delays in ST-Elevation Myocardial Infarction Care During the COVID-19 Lockdown: An Observational Study. CJC Open, 3(5), 565–573. https://doi.org/10.1016/j.cjco.2020.12.009
Costa, F., Tijssen, J. G., Ariotti, S., Giatti, S., Moscarella, E., Guastaroba, P., … Valgimigli, M. (2015). Incremental value of the CRUSADE, ACUITY, and HAS-BLED risk scores for the prediction of hemorrhagic events after coronary stent implantation in patients undergoing long or short duration of dual antiplatelet therapy. Journal of the American Heart Association, 4(12), 1–15. https://doi.org/10.1161/JAHA.115.002524
Dou, Q., Wang, W., Wang, H., Ma, Y., Hai, S., Lin, X., … Dong, B. (2019). Prognostic value of frailty in elderly patients with acute coronary syndrome: A systematic review and meta-analysis. BMC Geriatrics, 19(1), 1–10. https://doi.org/10.1186/s12877-019-1242-8
El Ouazzani, J., Ghalem, A., El Ouazzani, G., Ismaili, N., & El Ouafi, N. (2018). Management of hyperglycemia during and in the immediate follow-up of acute coronary syndrome. Journal of the Saudi Heart Association, 30(2), 113–121. https://doi.org/10.1016/j.jsha.2017.08.003
GarcÃa-Blas, S., Cordero, A., Diez-Villanueva, P., Martinez-Avial, M., Ayesta, A., Ariza-Solé, A., … Bonanad, C. (2021). Acute coronary syndrome in the older patient. Journal of Clinical Medicine, 10(18), 1–16. https://doi.org/10.3390/jcm10184132
GarcÃa-GarcÃa, C., Ribas, N., Recasens, L. L., Meroño, O., Subirana, I., Fernández, A., … Elosua, R. (2017). In-hospital prognosis and long-term mortality of STEMI in a reperfusion network. “Head to head†analisys: Invasive reperfusion vs optimal medical therapy. BMC Cardiovascular Disorders, 17(1), 1–8. https://doi.org/10.1186/s12872-017-0574-6
Gong, X., Zhou, L., Dong, T., Ding, X., Zhao, H., Chen, H., & Li, H. (2022). Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China. American Journal of Emergency Medicine, 53, 68–72. https://doi.org/10.1016/j.ajem.2021.11.034
Her, A. Y., Choi, B. G., Rha, S. W., Kim, Y. H., Choi, C. U., & Jeong, M. H. (2020). The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension. PLoS ONE, 15(11 November), 1–11. https://doi.org/10.1371/journal.pone.0242314
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., … Gale, C. P. (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, 39(2), 119–177. https://doi.org/10.1093/eurheartj/ehx393
Ioannidis, J. P. A., & Katritsis, D. G. (2007). Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients. American Heart Journal, 154(6), 1065–1071. https://doi.org/10.1016/j.ahj.2007.07.049
Ji, H., Fang, L., Yuan, L., & Zhang, Q. (2019). Effects of exercise-based cardiac rehabilitation in patients with acute coronary syndrome: A meta-analysis. Medical Science Monitor, 25, 5015–5027. https://doi.org/10.12659/MSM.917362
Kastrati, A., Coughlan, J. J., & Ndrepepa, G. (2021). Primary PCI, Late Presenting STEMI, and the Limits of Time. Journal of the American College of Cardiology, 78(13), 1306–1308. https://doi.org/10.1016/j.jacc.2021.08.001
Kemenkes RI. (2018). Hasil Riset Kesehatan Dasar Tahun 2018. Kementrian Kesehatan RI, 53(9), 1689–1699.
Kim, J., Park, S. J., Choi, S., Seo, W. woo, & Lee, Y. J. (2021). Hospitalization for acute coronary syndrome increases the long-term risk of pneumonia: a population-based cohort study. Scientific Reports, 11(1), 1–9. https://doi.org/10.1038/s41598-021-89038-1
Lambert, L. J., Brophy, J. M., Racine, N., Rinfret, S., L’Allier, P. L., Brown, K. A., … Bogaty, P. (2016). Outcomes of Patients With ST-Elevation Myocardial Infarction Receiving and Not Receiving Reperfusion Therapy: The Importance of Examining All Patients. Canadian Journal of Cardiology, 32(11), 1325. https://doi.org/10.1016/j.cjca.2016.02.073
Löffler, A. I., & Kramer, C. M. (2018, July). Myocardial Viability Testing to Guide Coronary Revascularization. Interventional Cardiology Clinics. Elsevier Inc. https://doi.org/10.1016/j.iccl.2018.03.005
Maskoun, W., Mustafa, N., Mahenthiran, J., Gradus-Pizlo, I., Kamalesh, M., Feigenbaum, H., & Sawada, S. G. (2009). Wall motion abnormalities with low-dose dobutamine predict a high risk of cardiac death in medically treated patients with ischemic cardiomyopathy. Clinical Cardiology, 32(7), 403–409. https://doi.org/10.1002/clc.20558
McNair, P. W., Bilchick, K. C., & Keeley, E. C. (2019). Very late presentation in ST elevation myocardial infarction: Predictors and long-term mortality. IJC Heart and Vasculature, 22, 156–159. https://doi.org/10.1016/j.ijcha.2019.02.002
Noble, S., & Roffi, M. (2017). Routine beta-blocker administration following acute myocardial infarction: Why still an unsolved issue? Journal of Thoracic Disease, 9(11), 4191–4194. https://doi.org/10.21037/jtd.2017.10.25
Ostadal, P. (2012). Statins as first-line therapy for acute coronary syndrome? Experimental and Clinical Cardiology, 17(4), 227–236.
Population, S. (2009). P Reve Nt Ing As Pirin-Rel Ated Ulcer C Omplic Ations Lansoprazole for the Prevention of Recurrences of Ulcer. English Journal, 346(26), 2033–2038.
Ralapanawa, U., Kumarasiri, P. V. R., Jayawickreme, K. P., Kumarihamy, P., Wijeratne, Y., Ekanayake, M., & Dissanayake, C. (2019). Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka. BMC Cardiovascular Disorders, 19(1). https://doi.org/10.1186/s12872-019-1217-x
Sim, H. W., Zheng, H., Richards, A. M., Chen, R. W., Sahlen, A., Yeo, K. K., … Chan, M. Y. (2020). Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization. Scientific Reports, 10(1), 1–9. https://doi.org/10.1038/s41598-020-72232-y
Sunamura, M., Ter Hoeve, N., Van Den Berg-Emons, R. J. G., Boersma, E., Van Domburg, R. T., & Geleijnse, M. L. (2018). Cardiac rehabilitation in patients with acute coronary syndrome with primary percutaneous coronary intervention is associated with improved 10-year survival. European Heart Journal - Quality of Care and Clinical Outcomes, 4(3), 168–172. https://doi.org/10.1093/ehjqcco/qcy001
Violi, F., Calvieri, C., Ferro, D., & Pignatelli, P. (2013). Statins as antithrombotic drugs. Circulation, 127(2), 251–257. https://doi.org/10.1161/CIRCULATIONAHA.112.145334
Yang, J. H., Hahn, J. Y., Song, Y. Bin, Choi, S. H., Choi, J. H., Lee, S. H., … Gwon, H. C. (2014). Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: Prospective cohort study. BMJ (Online), 349(November), 1–12. https://doi.org/10.1136/bmj.g6650
Authors
Copyright (c) 2023 Iswandi Darwis, Anggoro Budi Hartapo, Muhammad Gahan Sarwiko
This work is licensed under a Creative Commons Attribution 4.0 International License.
Qanun Medika by FK UM Surabaya is liscence under Lisensi Creative Commons Atribusi 4.0 Internasional.
